Mark R. Ziebell

2022

In 2022, Mark R. Ziebell earned a total compensation of $1.3M as Vice President, General Counsel and Corporate Secretary at Peregrine Pharmaceuticals, a 22% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$247,075
Salary$414,000
Stock Awards$580,260
Other$50,373
Total$1,291,708

Ziebell received $580.3K in stock awards, accounting for 45% of the total pay in 2022.

Ziebell also received $247.1K in non-equity incentive plan, $414K in salary and $50.4K in other compensation.

Rankings

In 2022, Mark R. Ziebell's compensation ranked 2,540th out of 5,756 executives tracked by ExecPay. In other words, Ziebell earned more than 55.9% of executives.

ClassificationRankingPercentile
All
2,540
out of 5,756
56th
Division
Manufacturing
1,402
out of 3,133
55th
Major group
Chemicals And Allied Products
638
out of 1,419
55th
Industry group
Drugs
592
out of 1,320
55th
Industry
Pharmaceutical Preparations
424
out of 966
56th
Source: SEC filing on August 29, 2022.

Ziebell's colleagues

We found two more compensation records of executives who worked with Mark R. Ziebell at Peregrine Pharmaceuticals in 2022.

2022

Nicholas Green

Peregrine Pharmaceuticals

Chief Executive Officer

2022

Daniel Hart

Peregrine Pharmaceuticals

Chief Financial Officer

News

You may also like